Literature DB >> 8737408

Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells.

L Taupenot1, J Ciesielski-Treska, G Ulrich, S Chasserot-Golaz, D Aunis, M F Bader.   

Abstract

Chromogranin A is an ubiquitous 48,000 mol. wt secretory protein stored and released from many neuroendocrine cells and neurons. In human brain, chromogranin A is a common feature of regions that are known to be affected by various neurodegenerative pathologies such as Alzheimer's, Parkinson's and Pick's diseases. Brain degenerative areas are generally infiltrated by activated microglial cells, the resident macrophage cell population within the central nervous system. Here, we report that both recombinant human chromogranin A and chromogranin A purified from bovine chromaffin granules trigger drastic morphological changes in rat microglial cells maintained in culture. Microglial cells exposed to chromogranin A adopted a flattened amoeboid shape and, this change was associated with an accumulation of actin in the subplasmalemmal region, as observed by immunocytochemistry and confocal laser microscopy. In single microglial cells loaded with indo-1, chromogranin A elicited a rapid and transient increase in [Ca2+]i which preceded the reorganization of actin cytoskeleton. The activity of nitric oxide synthase was estimated by measuring the accumulation of nitrite in the culture medium. Both recombinant human chromogranin A and bovine chromogranin A triggered an important accumulation of nitrite comparable to that induced by lipopolysaccharide, a well-known activator of microglia. The effect of chromogranin A was dose dependent, inhibited by N omega-nitro-L-arginine methyl ester, a competitive inhibitor of nitric oxide synthase, and by cycloheximide, an inhibitor of protein synthesis. These findings suggest that chromogranin A induces an activated phenotype of microglia, and thus may have a role in the pathogenesis of neuronal degeneration in the brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737408     DOI: 10.1016/0306-4522(96)83172-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

Review 1.  Catestatin: a multifunctional peptide from chromogranin A.

Authors:  Sushil K Mahata; Manjula Mahata; Maple M Fung; Daniel T O'Connor
Journal:  Regul Pept       Date:  2010-01-28

Review 2.  The future use of complement inhibitors for the treatment of neurological diseases.

Authors:  E G McGeer; P L McGeer
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 3.  Antibacterial peptides are present in chromaffin cell secretory granules.

Authors:  M H Metz-Boutigue; Y Goumon; K Lugardon; J M Strub; D Aunis
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

4.  Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

Authors:  L Taupenot; S K Mahata; H Wu; D T O'Connor
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion.

Authors:  Tomris Mustafa; Maurizio Grimaldi; Lee E Eiden
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

6.  Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Authors:  S K Mahata; D T O'Connor; M Mahata; S H Yoo; L Taupenot; H Wu; B M Gill; R J Parmer
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity.

Authors:  A Bal-Price; G C Brown
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 8.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

9.  Microglia in close vicinity of glioma cells: correlation between phenotype and metabolic alterations.

Authors:  Pierre Voisin; Véronique Bouchaud; Michel Merle; Philippe Diolez; Laura Duffy; Kristian Flint; Jean-Michel Franconi; Anne-Karine Bouzier-Sore
Journal:  Front Neuroenergetics       Date:  2010-10-12

Review 10.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.